Matthew Laybourne is a dedicated professional in the bio-pharmaceutical industry, focused on generating impactful evidence to enhance patient care. With a foundation in clinical research gained from roles at esteemed institutions such as the Institute of Cancer Research and The Royal Marsden NHS Foundation Trust, Matthew transitioned to Amgen where they are actively engaged in a leadership rotational program (ACCELERATE). Their experience spans clinical trial design and execution, as well as strategic roles in Global Medical Operations and Medical Value and Access, all aimed at improving treatment accessibility for patients. Matthew's career reflects a commitment to learning and leadership, inspired by early experiences with patients facing life-threatening illnesses.
This person is not in the org chart
This person is not in any teams
This person is not in any offices